These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 5441698)
1. [Limits of drug advertisement with scientific works]. Reichert K Ther Ggw; 1970 Feb; 109(2):272 passim. PubMed ID: 5441698 [No Abstract] [Full Text] [Related]
2. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries]. Burow W; Lüllmann H Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578 [No Abstract] [Full Text] [Related]
3. [Reform in food legislation. Laws for advertising of cosmetics are under consideration]. Zahnarztl Mitt; 1971 Apr; 61(7):322-3. PubMed ID: 5280113 [No Abstract] [Full Text] [Related]
4. [Medical questions with respect to the introduction of new drug specialties into the German Federal Republic]. Grillmaier JB Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):315-31. PubMed ID: 5365590 [No Abstract] [Full Text] [Related]
5. [Traffic in tobacco products. Proposals for the reform of the food laws]. Schmidt F Munch Med Wochenschr; 1972 Sep; 114(36):1547-50. PubMed ID: 4677818 [No Abstract] [Full Text] [Related]
6. [Health aspects of the new food law]. Schiedermaier Dtsch Med Wochenschr; 1975 Jun; 100(23):1305-8. PubMed ID: 1140089 [No Abstract] [Full Text] [Related]
7. [Social pharmacology or physician scientific education?]. Kienle G MMW Munch Med Wochenschr; 1980 Dec; 122(51-52):1825-6. PubMed ID: 6780873 [No Abstract] [Full Text] [Related]
9. Impact of the West German drug law upon development of clinical pharmacology. Kampffmeyer H Clin Pharmacol Ther; 1974 Sep; 16(3):616-9. PubMed ID: 4413783 [No Abstract] [Full Text] [Related]
10. [Experience with phase I of clinical pharmacology in the registration of drugs]. von Eickstedt KW Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1677-8. PubMed ID: 4801617 [No Abstract] [Full Text] [Related]
11. The present status of clinical pharmacology in Yugoslavia. Vrhovac B Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):42-6. PubMed ID: 4924328 [No Abstract] [Full Text] [Related]
13. [What are the implications of the drug advertising law for the health-officer?]. Aye E Offentl Gesundheitsdienst; 1966 Jun; 28(6):211-22. PubMed ID: 5963786 [No Abstract] [Full Text] [Related]
14. [Disposition court decides: a physician may also advertise with drug names]. MMW Fortschr Med; 2004 Aug; 146(33-34):49. PubMed ID: 15526630 [No Abstract] [Full Text] [Related]
15. [Possibilities and limits of drug supervision]. Homann G Med Klin; 1970 Aug; 65(35):1518-20. PubMed ID: 5516116 [No Abstract] [Full Text] [Related]
16. US Congress to consider limits on DTCA. Guthrie P CMAJ; 2007 May; 176(10):1404. PubMed ID: 17485685 [No Abstract] [Full Text] [Related]
17. [Pharmaceutical advertising and scientific papers versus dermatology and venerology]. László A; Micánek B; Oser M Hautarzt; 1970 Jan; 21(1):32-3. PubMed ID: 5538160 [No Abstract] [Full Text] [Related]
18. [Prohibition of advertising and relevant information offered to the public]. Eglin O Dtsch Med Wochenschr; 1974 Sep; 99(36):1787. PubMed ID: 4448123 [No Abstract] [Full Text] [Related]
19. [Laboratory advertising and professional medical law]. Kurz G Dtsch Med Wochenschr; 1975 Oct; 100(43):2233. PubMed ID: 1175473 [No Abstract] [Full Text] [Related]
20. [Drug legislation and drug evaluation. Important aspects discussed in West Germany]. Pedersen PA Ugeskr Laeger; 1975 Feb; 137(6):333-5. PubMed ID: 1136049 [No Abstract] [Full Text] [Related] [Next] [New Search]